{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T03:33:25Z","timestamp":1768880005953,"version":"3.49.0"},"reference-count":236,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jceh.2020.09.005","type":"journal-article","created":{"date-parts":[[2020,10,9]],"date-time":"2020-10-09T03:44:03Z","timestamp":1602215043000},"page":"354-386","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease"],"prefix":"10.1016","volume":"11","author":[{"given":"Anil","family":"Arora","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashish","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narayan","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Duseja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subrat K.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay K.","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakesh","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil C.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anil K.","family":"Bhalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narendra S.","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogesh K.","family":"Chawla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Radha K.","family":"Dhiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinod K.","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natarajan","family":"Gopalakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Umapati N.","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv","family":"Jasuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay","family":"Kher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaushal","family":"Madan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rakhi","family":"Maiwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra P.","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suman L.","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaurav","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajendra","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pankaj","family":"Puri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramesh R.","family":"Rai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sree B.","family":"Raju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devinder S.","family":"Rana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padaki N.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manish","family":"Rathi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivek A.","family":"Saraswat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiv","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Shalimar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shivaram P.","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashwani K.","family":"Singal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arvinder S.","family":"Soin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil","family":"Taneja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh","family":"Varughese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2020.09.005_bib1","first-page":"72","article-title":"Hepatitis B virus and hepatitis C virus co-infection in hemodialysis patients: a retrospective study from a tertiary care hospital of North India","volume":"7","author":"Malhotra","year":"2016","journal-title":"J\u00a0Nat Sci Biol Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jceh.2015.04.004","article-title":"Hepatitis C virus infection in patients with end-stage renal disease: a study from a tertiary care centre in India","volume":"6","author":"Arora","year":"2016","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib3","first-page":"345","article-title":"Utility of hepatitis C virus RNA as the screening test for diagnosing hepatitis C virus infection in hemodialysis patients","volume":"9","author":"Mahajan","year":"2017","journal-title":"J\u00a0Lab Physicians"},{"key":"10.1016\/j.jceh.2020.09.005_bib4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.20546\/ijcmas.2017.607.169","article-title":"Seroprevalence of hepatitis C virus infection among chronic kidney disease patients on maintenance hemodialysis in a tertiary care hospital","volume":"6","author":"Somsundaram","year":"2017","journal-title":"Int J Curr Microbiol Appl Sci"},{"key":"10.1016\/j.jceh.2020.09.005_bib5","series-title":"Euroasian J Hepato-Gastroenterol","first-page":"10","article-title":"Prevalence of hepatitis B and C among hemodialysis patients of Tripura, India","volume":"vol. 2","author":"Bhaumik","year":"2012"},{"key":"10.1016\/j.jceh.2020.09.005_bib6","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.kint.2018.06.011","article-title":"Executive summary of the 2018 KDIGO Hepatitis C in CKD Guideline: welcoming advances in evaluation and management","volume":"94","author":"Jadoul","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib7","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1053\/j.ajkd.2014.05.019","article-title":"CKD and nonalcoholic fatty liver disease","volume":"64","author":"Targher","year":"2014","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"10.1016\/j.jceh.2020.09.005_bib8","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000350158","article-title":"Chronic kidney disease and nonalcoholic Fatty liver disease proven by transient elastography","volume":"37","author":"Mikolasevic","year":"2013","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.jceh.2020.09.005_bib9","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.2337\/dc15-1182","article-title":"Fatty liver and chronic kidney disease: novel mechanistic insights and therapeutic opportunities","volume":"39","author":"Musso","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jceh.2020.09.005_bib10","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib11","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000492587","article-title":"Renal failure in patients with liver cirrhosis: novel classifications, biomarkers, treatment","volume":"34","author":"Appenrodt","year":"2018","journal-title":"Vis Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib12","first-page":"438","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute-on-chronic liver failure","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2020.09.005_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1053\/ajkd.2003.50035","article-title":"Assessing renal function in cirrhotic patients: problems and pitfalls","volume":"41","author":"Sherman","year":"2003","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"},{"key":"10.1016\/j.jceh.2020.09.005_bib14","doi-asserted-by":"crossref","DOI":"10.1097\/MEG.0000000000001347","article-title":"Clinical utility of urinary neutrophil gelatinase-associated lipocalin and serum cystatin C in a cohort of liver cirrhosis patients with renal dysfunction: a challenge in the diagnosis of hepatorenal syndrome","author":"Gomaa","year":"2019","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib15","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1373\/clinchem.2005.0525144","article-title":"Recommendations for improving serum creatinine measurement: a report from the laboratory working group of the national kidney disease education Program","volume":"52","author":"Myers","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/j.jceh.2020.09.005_bib16","doi-asserted-by":"crossref","first-page":"c179","DOI":"10.1159\/000339789","article-title":"KDIGO clinical practice guidelines for acute kidney injury","volume":"120","author":"Khwaja","year":"2012","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jceh.2020.09.005_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1055\/s-0038-1661372","article-title":"Renal function in cirrhosis: a critical review of available tools","volume":"38","author":"Piano","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2020.09.005_bib18","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1159\/000188639","article-title":"Creatinine clearance: an inadequate marker of renal filtration in patients with early posthepatitic cirrhosis (Child A) without fluid retention and muscle wasting","volume":"70","author":"DeSanto","year":"1995","journal-title":"Nephron"},{"key":"10.1016\/j.jceh.2020.09.005_bib19","first-page":"342","article-title":"Glomerular filtration rate measurement in cirrhotic patients with renal failure","volume":"50","author":"Roy","year":"1998","journal-title":"Clin Nephrol"},{"key":"10.1016\/j.jceh.2020.09.005_bib20","first-page":"1617","article-title":"Measured creatinine clearance from timed urine collections substantially overestimates glomerular filtration rate in patients with liver cirrhosis: a systematic review and individual patient meta-analysis","volume":"20","author":"Proulx","year":"2005","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc."},{"key":"10.1016\/j.jceh.2020.09.005_bib21","first-page":"173","article-title":"Measurement of serum creatinine--current status and future goals","volume":"27","author":"Peake","year":"2006","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.jceh.2020.09.005_bib22","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.jhep.2016.05.025","article-title":"Kidney biomarkers in cirrhosis","volume":"65","author":"Francoz","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib23","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1093\/clinchem\/46.5.712","article-title":"Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis","volume":"46","author":"Woitas","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/j.jceh.2020.09.005_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/gut.50.1.106","article-title":"Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver","volume":"50","author":"Gerbes","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.09.005_bib25","article-title":"Role of Cystatin C and glomerular filtration rate in diagnosis of kidney impairment in hepatic cirrhosis patients","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2020.09.005_bib26","doi-asserted-by":"crossref","first-page":"c195","DOI":"10.1159\/000321384","article-title":"Renal function in patients with liver cirrhosis","volume":"118","author":"Chen","year":"2011","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.jceh.2020.09.005_bib27","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.3748\/wjg.15.3631","article-title":"Spot urinary sodium for assessing dietary sodium restriction in cirrhotic ascites","volume":"15","author":"El-Bokl","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib28","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.2215\/CJN.04320510","article-title":"Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients","volume":"6","author":"Liu","year":"2011","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.jceh.2020.09.005_bib29","first-page":"1108","article-title":"Impact of liver fibrosis staging in hepatitis C virus (HCV) patients with kidney failure","volume":"29","author":"Jadoul","year":"2014","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc."},{"key":"10.1016\/j.jceh.2020.09.005_bib30","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/ki.2013.249","article-title":"Treatment of hepatitis B in patients with chronic kidney disease","volume":"84","author":"Pipili","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.22742","article-title":"American association for the study of liver diseases. Liver biopsy","volume":"49","author":"Rockey","year":"2009","journal-title":"Hepatol Baltim Md"},{"issue":"109","key":"10.1016\/j.jceh.2020.09.005_bib32","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","year":"2008","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/j.jceh.2020.09.005_bib33","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MEG.0000000000001045","article-title":"Noninvasive fibrosis markers and chronic kidney disease among adults with nonalcoholic fatty liver in USA","volume":"30","author":"Wijarnpreecha","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib34","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.21681","article-title":"Simple blood tests as noninvasive markers of liver fibrosis in hemodialysis patients\u00a0with\u00a0chronic hepatitis C virus infection","volume":"46","author":"Schiavon","year":"2007","journal-title":"Hepatol Baltim\u00a0Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib35","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1007\/s10620-017-4777-6","article-title":"Assessment of liver fibrosis by transient elastography should Be done after hemodialysis in end stage renal disease patients with liver disease","volume":"62","author":"Taneja","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.09.005_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-016-9760-3","article-title":"Asian-Pacific Association for the Study of the Liver (APASL) consensus guidelines on invasive and non-invasive assessment of hepatic fibrosis: a 2016 update","volume":"11","author":"Shiha","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib37","doi-asserted-by":"crossref","first-page":"15","DOI":"10.4103\/0971-4065.181298","article-title":"Guidelines for vaccination in patients with chronic kidney disease","volume":"26","year":"2016","journal-title":"Indian J Nephrol"},{"key":"10.1016\/j.jceh.2020.09.005_bib38","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1515\/jtim-2015-0018","article-title":"Viral hepatitis in hemodialysis: an update","volume":"3","author":"Bernieh","year":"2015","journal-title":"J\u00a0Transl Intern Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib39","first-page":"183","article-title":"Prevention of viral transmission in HD units: the value of isolation","volume":"17","author":"Karkar","year":"2006","journal-title":"Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab"},{"key":"10.1016\/j.jceh.2020.09.005_bib40","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1492-7535.2005.01129.x","article-title":"Chronic viral hepatitis in hemodialysis patients","volume":"9","author":"Tang","year":"2005","journal-title":"Hemodial Int Int Symp Home Hemodial"},{"key":"10.1016\/j.jceh.2020.09.005_bib41","series-title":"StatPearls. StatPearls Publishing","article-title":"Universal precautions","author":"Broussard","year":"2018"},{"key":"10.1016\/j.jceh.2020.09.005_bib42","first-page":"377","article-title":"Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings","volume":"37","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jceh.2020.09.005_bib43","article-title":"Universal precautions: necessary safety procedures when handling human blood, body fluids, and specimens","volume":"118","author":"Bierer","year":"2017","journal-title":"Curr Protoc Im"},{"key":"10.1016\/j.jceh.2020.09.005_bib44","first-page":"548","article-title":"Prevention of hepatitis C virus in hemodialysis patients: five years experience from a single center","volume":"21","author":"Mohamed","year":"2010","journal-title":"Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab"},{"key":"10.1016\/j.jceh.2020.09.005_bib45","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic hemodialysis patients","volume":"50","year":"2001","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep"},{"key":"10.1016\/j.jceh.2020.09.005_bib46","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jceh.2018.06.010","article-title":"INASL guidelines on management of hepatitis B virus infection in patients receiving chemotherapy, biologicals, immunosupressants, or corticosteroids","volume":"8","author":"Arora","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jceh.2017.12.001","article-title":"INASL position Statements on prevention, diagnosis and management of hepatitis B virus infection in India: the Andaman Statements","volume":"8","author":"Arora","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.4254\/wjh.v7.i5.761","article-title":"Is hemodialysis a reason for unresponsiveness to hepatitis B vaccine? Hepatitis B virus and dialysis therapy","volume":"7","author":"Sit","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib49","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1007\/s11033-013-2809-7","article-title":"Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection","volume":"40","author":"Grzegorzewska","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jceh.2020.09.005_bib50","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/1471-2369-13-97","article-title":"Association of response to hepatitis B vaccination and survival in dialysis patients","volume":"13","author":"Lin","year":"2012","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.jceh.2020.09.005_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib52","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1177\/039139881003300601","article-title":"Therapy with nucleos(t)ide analogues: current role in dialysis patients","volume":"33","author":"Fabrizi","year":"2010","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jceh.2020.09.005_bib53","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1080\/08860220802406377","article-title":"Hemodialysis reduces the viral load in uremic patients with chronic hepatitis B infection","volume":"30","author":"Tseng","year":"2008","journal-title":"Ren Fail"},{"key":"10.1016\/j.jceh.2020.09.005_bib54","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/apt.12538","article-title":"Review article: nucleos(t)ide analogues in patients with chronic hepatitis B virus infection and chronic kidney disease","volume":"39","author":"Pipili","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.09.005_bib56","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/ctr.12410","article-title":"Entecavir treatment in kidney transplant recipients infected with hepatitis B","volume":"28","author":"Yap","year":"2014","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2020.09.005_bib57","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3851\/IMP2097","article-title":"A\u00a0novel experience of antiviral therapy for chronic hepatitis B in renal transplant recipients","volume":"17","author":"Hu","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/j.jceh.2020.09.005_bib58","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/apt.14682","article-title":"Using the chronic kidney disease guidelines to evaluate the renal safety of tenofovir disoproxil fumarate in hepatitis B patients","volume":"47","author":"Tsai","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.09.005_bib59","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/apt.13659","article-title":"Review article: long-term safety of nucleoside and nucleotide analogues in HBV-monoinfected patients","volume":"44","author":"Lampertico","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.09.005_bib60","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1097\/TP.0b013e3182100f59","article-title":"Tenofovir therapy in hepatitis B virus-positive solid-organ transplant recipients","volume":"91","author":"Daud\u00e9","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.09.005_bib61","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s12664-013-0325-2","article-title":"Increased eGFR with telbivudine in combination therapy of chronic hepatitis B infection","volume":"33","author":"Amarapurkar","year":"2014","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib62","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S2468-1253(16)30107-8","article-title":"Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of patients with HBeAg-negative chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial","volume":"1","author":"Buti","year":"2016","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib63","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jhep.2017.11.039","article-title":"96\u202fweeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection","volume":"68","author":"Agarwal","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib64","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4254\/wjh.v7.i2.189","article-title":"Antiviral treatment for chronic hepatitis B in renal transplant patients","volume":"7","author":"Ridruejo","year":"2015","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib65","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2893.2007.00868.x","article-title":"The impact of hepatitis C virus infection on survival in dialysis patients: meta-analysis of observational studies","volume":"14","author":"Fabrizi","year":"2007","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2020.09.005_bib66","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/cid\/ciy585","article-title":"Hepatitis C guidance 2018 update: AASLD-IDSA recommendations for testing, managing, and treating hepatitis C virus infection","volume":"67","year":"2018","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"10.1016\/j.jceh.2020.09.005_bib67","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1016\/S0140-6736(15)00349-9","article-title":"Grazoprevir plus elbasvir in treatment-naive and treatment-experienced patients with hepatitis C virus genotype 1 infection and stage 4-5 chronic kidney disease (the C-SURFER study): a combination phase 3 study","volume":"386","author":"Roth","year":"2015","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jceh.2020.09.005_bib68","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1056\/NEJMoa1704053","article-title":"Glecaprevir and pibrentasvir in patients with HCV and severe renal impairment","volume":"377","author":"Gane","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib69","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4103\/ijmr.IJMR_679_15","article-title":"Newer direct-acting antivirals for hepatitis C virus infection: perspectives for India","volume":"146","author":"Gupta","year":"2017","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.jceh.2020.09.005_bib70","article-title":"Results of sofosbuvir plus ribavirin in patients with hepatitis C related decompensated cirrhosis","author":"Tmu","year":"2018","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib71","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40264-016-0420-2","article-title":"Pharmacokinetics, efficacy, and safety of hepatitis C virus drugs in patients with liver and\/or renal impairment","volume":"39","author":"Smolders","year":"2016","journal-title":"Drug Saf"},{"key":"10.1016\/j.jceh.2020.09.005_bib72","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jhep.2015.06.004","article-title":"Safety, efficacy and tolerability of half-dose sofosbuvir plus simeprevir in treatment of Hepatitis C in patients with end stage renal disease","volume":"63","author":"Bhamidimarri","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib73","first-page":"798","article-title":"Sofosbuvir and simeprevir in hepatitis C genotype 1-patients with end-stage renal disease on\u00a0haemodialysis or GFR <30 ml\/min","volume":"36","author":"Nazario","year":"2016","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jceh.2020.09.005_bib74","first-page":"807","article-title":"Safety and efficacy of sofosbuvir-containing regimens in hepatitis C-infected patients with impaired renal function","volume":"36","author":"Saxena","year":"2016","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jceh.2020.09.005_bib75","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1007\/s10620-018-4979-6","article-title":"Low-dose sofosbuvir is safe and effective in treating chronic hepatitis C in patients with severe renal impairment or end-stage renal disease","volume":"63","author":"Taneja","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.09.005_bib76","article-title":"Daclatasvir and reduced-dose sofosbuvir: an effective and pangenotypic treatment for hepatitis C in patients with eGFR <30 ml\/min","author":"Goel","year":"2018","journal-title":"Nephrol Carlton Vic"},{"key":"10.1016\/j.jceh.2020.09.005_bib77","first-page":"2137","article-title":"Generic sofosbuvir-based direct-acting antivirals in hepatitis C virus-infected patients with chronic kidney disease","volume":"38","author":"Kumar null","year":"2018","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jceh.2020.09.005_bib78","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1111\/jvh.12983","article-title":"Sofosbuvir with NS5A inhibitors in hepatitis C virus infection with severe renal insufficiency","volume":"25","author":"Singh","year":"2018","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.jceh.2020.09.005_bib79","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ekir.2017.04.003","article-title":"Hemodialysis patients treated for hepatitis C using a sofosbuvir-based regimen","volume":"2","author":"Agarwal","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.jceh.2020.09.005_bib81","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jhep.2018.03.026","article-title":"Electronic address: easloffice@easloffice.eu, European association for the study of the liver. EASL recommendations on treatment of hepatitis C 2018","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib82","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12072-018-9915-5","article-title":"APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment?","volume":"13","author":"Kanda","year":"2019","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3350\/cmh.2017.0059","article-title":"Evolution of glomerular filtration rates and neutrophil gelatinase-associated lipocalin during treatment with direct acting antivirals","volume":"24","author":"Strazzulla","year":"2018","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib84","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S0168-8278(18)30262-9","article-title":"Estimated glomerular filtration rate variations and direct acting antivirals treatment for chronic hepatitis C: a retrospective longitudinal study","volume":"68","author":"Mallet","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib85","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","author":"Sawinski","year":"2016","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jceh.2020.09.005_bib86","article-title":"Efficacy and safety of direct acting antivirals in kidney transplant recipients with chronic hepatitis C virus infection","volume":"11","author":"Lin","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2020.09.005_bib87","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/nep.13109","article-title":"Successful treatment of chronic hepatitis C infection with directly acting antivirals in renal transplant recipients","volume":"23","author":"Taneja","year":"2018","journal-title":"Nephrol Carlton Vic"},{"key":"10.1016\/j.jceh.2020.09.005_bib88","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s12664-017-0745-5","article-title":"Experience with direct acting anti-viral agents for treating hepatitis C virus infection in renal transplant recipients","volume":"36","author":"Goel","year":"2017","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib89","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1056\/NEJMra1503519","article-title":"Cause, pathogenesis, and treatment of nonalcoholic steatohepatitis","volume":"377","author":"Diehl","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib90","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.metabol.2017.11.003","article-title":"Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: a systematic review and meta-analysis","volume":"79","author":"Mantovani","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2020.09.005_bib91","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2010.07.022","article-title":"Nonalcoholic steatohepatitis and increased risk of chronic kidney disease","volume":"60","author":"Yasui","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/j.jceh.2020.09.005_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13201","article-title":"Metabolic syndrome and its components are associated with increased chronic kidney disease risk: evidence from a meta-analysis on 11 109 003 participants from 66 studies","author":"Alizadeh","year":"2018","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jceh.2020.09.005_bib93","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ecl.2013.09.009","article-title":"Metabolic syndrome","volume":"43","author":"Samson","year":"2014","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.jceh.2020.09.005_bib94","first-page":"163","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J\u00a0Assoc Phys India"},{"key":"10.1016\/j.jceh.2020.09.005_bib95","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1055\/s-0028-1091984","article-title":"Current and emerging therapies in nonalcoholic fatty liver disease","volume":"28","author":"Kashi","year":"2008","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jceh.2020.09.005_bib96","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib97","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.jacc.2011.04.041","article-title":"Effects of beta-adrenergic antagonists in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"58","author":"Badve","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jceh.2020.09.005_bib98","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1365-2044.2004.03877.x","article-title":"Vasopressin and terlipressin: pharmacology and its clinical relevance","volume":"59","author":"Kam","year":"2004","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jceh.2020.09.005_bib99","first-page":"CD000193","article-title":"Somatostatin analogues for acute bleeding oesophageal varices","volume":"1","author":"G\u00f8tzsche","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2020.09.005_bib100","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib101","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites","volume":"117","author":"Runyon","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib102","article-title":"Chronic kidney disease correlates with increased risk of pulmonary tuberculosis before initiating renal replacement therapy: a cohort study in Taiwan","volume":"97","author":"Cheng","year":"2018","journal-title":"Medicine (Baltim)"},{"key":"10.1016\/j.jceh.2020.09.005_bib103","first-page":"291","article-title":"Risk factors associated with the development of active tuberculosis among patients with advanced chronic kidney disease","volume":"77","author":"Moran","year":"2018","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.jceh.2020.09.005_bib104","first-page":"681","article-title":"An update on the management of latent tuberculosis infection and active disease in patients with chronic kidney disease","volume":"127","author":"Myall","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib105","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jceh.2012.07.007","article-title":"A\u00a0guide to the management of tuberculosis in patients with chronic liver disease","volume":"2","author":"Dhiman","year":"2012","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib106","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3109\/0886022X.2010.541582","article-title":"Clinical spectrum of renal disorders in patients with cirrhosis of liver","volume":"33","author":"Prakash","year":"2011","journal-title":"Ren Fail"},{"key":"10.1016\/j.jceh.2020.09.005_bib107","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/gastro\/gox009","article-title":"Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome","volume":"5","author":"Bucsics","year":"2017","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/j.jceh.2020.09.005_bib108","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.3748\/wjg.v18.i24.3035","article-title":"Kidneys in chronic liver diseases","volume":"18","author":"Hartleb","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib109","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14218\/JCTH.2015.00015","article-title":"Acute kidney injury in patients with cirrhosis","volume":"3","author":"Russ","year":"2015","journal-title":"J\u00a0Clin Transl Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib110","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/hep.25735","article-title":"Association of AKI with mortality and complications in hospitalized patients with cirrhosis","volume":"57","author":"Belcher","year":"2013","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib111","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.jhep.2013.03.039","article-title":"Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites","volume":"59","author":"Piano","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib112","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.jhep.2013.04.036","article-title":"A\u00a0modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis","volume":"59","author":"Fagundes","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib113","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/gutjnl-2011-301255","article-title":"Acute kidney injury in decompensated cirrhosis","volume":"62","author":"Tsien","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.09.005_bib114","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1097\/MCG.0b013e31822e8e12","article-title":"Acute kidney injury network criteria as a predictor of hospital mortality in cirrhotic patients with ascites","volume":"46","author":"de Carvalho","year":"2012","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib115","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1053\/j.gastro.2013.08.051","article-title":"New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection","volume":"145","author":"Wong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib116","first-page":"65","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2020.09.005_bib117","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1136\/gutjnl-2014-307526","article-title":"Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.09.005_bib118","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jhep.2014.12.029","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"62","author":"Angeli","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib119","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL)","volume":"3","author":"Sarin","year":"2009","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib120","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s12072-014-9580-2","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL) 2014","volume":"8","author":"Sarin","year":"2014","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib121","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib122","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.kint.2017.04.048","article-title":"Acute kidney injury in acute-on-chronic liver failure: where does hepatorenal syndrome fit?","volume":"92","author":"Davenport","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib123","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v24.i21.2300","article-title":"Acute kidney injury in acute-on-chronic liver failure is different from in decompensated cirrhosis","volume":"24","author":"Jiang","year":"2018","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib124","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.09.005_bib125","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.jhep.2013.10.036","article-title":"To close the stable door before the horse has bolted","volume":"60","author":"Thalheimer","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib126","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.jhep.2014.10.047","article-title":"A\u00a0cut-off serum creatinine value of 1.5 mg\/dl for AKI--to be or not to be","volume":"62","author":"Wong","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib127","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12072-017-9822-1","article-title":"AKI persistence at 48 h predicts mortality in patients with acute on chronic liver failure","volume":"11","author":"Maiwall","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jceh.2020.09.005_bib128","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1053\/j.gastro.2008.02.014","article-title":"A\u00a0randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndrome","volume":"134","author":"Sanyal","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib129","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib130","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1007\/s10620-007-9919-9","article-title":"Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome","volume":"53","author":"Neri","year":"2008","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.09.005_bib131","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/apt.14052","article-title":"Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus\u00a0albumin in a pooled analysis of the OT-0401 and\u00a0REVERSE\u00a0randomised clinical studies","volume":"45","author":"Sanyal","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2020.09.005_bib132","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/j.1440-1746.2009.06132.x","article-title":"Terlipressin therapy for reversal of type 1 hepatorenal syndrome: a meta-analysis of randomized controlled trials","volume":"25","author":"Sagi","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib133","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/039139880903200303","article-title":"Terlipressin for hepatorenal syndrome: a meta-analysis of randomized trials","volume":"32","author":"Fabrizi","year":"2009","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.jceh.2020.09.005_bib134","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/hep.23286","article-title":"Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome","volume":"51","author":"Gluud","year":"2010","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib135","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jhep.2007.04.010","article-title":"Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study","volume":"47","author":"Alessandria","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib136","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/j.1572-0241.2008.01828.x","article-title":"An open label, pilot, randomized controlled trial of noradrenaline versus terlipressin in the treatment of type 1 hepatorenal syndrome and predictors of response","volume":"103","author":"Sharma","year":"2008","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib137","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0107466","article-title":"Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis","volume":"9","author":"Nassar Junior","year":"2014","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2020.09.005_bib138","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s12664-018-0876-3","article-title":"Noradrenaline versus terlipressin in the management of type 1 hepatorenal syndrome: a randomized controlled study","volume":"37","author":"Saif","year":"2018","journal-title":"Indian J Gastroenterol Off J Indian Soc Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib139","article-title":"Terlipressin is superior to noradrenaline in the management of acute kidney injury in acute on chronic liver failure","author":"Arora","year":"2018","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib140","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: a randomized trial","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib141","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jceh.2015.08.003","article-title":"Randomized controlled trial comparing the efficacy of terlipressin and albumin with a combination of concurrent dopamine, furosemide, and albumin in hepatorenal syndrome","volume":"5","author":"Srivastava","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib142","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib143","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2010.11.020","article-title":"Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics","volume":"55","author":"Boyer","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib144","first-page":"1792","article-title":"Association between grade of acute on chronic liver failure and response to terlipressin and albumin in patients with hepatorenal syndrome","volume":"16","author":"Piano","year":"2018","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2020.09.005_bib145","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.jhep.2013.12.032","article-title":"Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis","volume":"60","author":"Rodr\u00edguez","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib146","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1002\/hep.26687","article-title":"Type-1 hepatorenal syndrome associated with infections in cirrhosis: natural history, outcome of kidney function, and survival","volume":"59","author":"Barreto","year":"2014","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib147","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.jhep.2014.02.001","article-title":"Type-1 hepatorenal syndrome in patients with cirrhosis and infection vs. sepsis-induced acute kidney injury: what matters?","volume":"60","author":"Francoz","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib148","first-page":"398","article-title":"Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis","volume":"33","author":"Shah","year":"2013","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"key":"10.1016\/j.jceh.2020.09.005_bib149","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2011.11.024","article-title":"Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression","volume":"56","author":"Shah","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib150","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.jcrc.2015.05.003","article-title":"Mean arterial pressure and mean perfusion pressure deficit in septic acute kidney injury","volume":"30","author":"Wong","year":"2015","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jceh.2020.09.005_bib151","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1159\/000329235","article-title":"Hepatorenal syndrome","volume":"174","author":"Angeli","year":"2011","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jceh.2020.09.005_bib152","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1097\/01.tp.0000241104.58576.e6","article-title":"Comparison of renal allograft outcomes in combined liver-kidney transplantation versus subsequent kidney transplantation in liver transplant recipients: analysis of UNOS Database","volume":"82","author":"Simpson","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.09.005_bib153","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1399-0012.2011.01450.x","article-title":"The impact of renal replacement therapy before or after living donor liver transplantation","volume":"26","author":"Ikegami","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2020.09.005_bib154","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1016\/j.transproceed.2013.02.127","article-title":"Experience of combined liver-kidney transplantation for acute-on-chronic liver failure patients with renal dysfunction","volume":"45","author":"Xing","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.09.005_bib155","first-page":"440","article-title":"Pretransplant predictors of recovery of renal function after liver transplantation","volume":"16","author":"Northup","year":"2010","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jceh.2020.09.005_bib156","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1007\/s10620-018-5170-9","article-title":"Chances of renal recovery or liver transplantation after hospitalization for alcoholic liver disease requiring dialysis","volume":"63","author":"Lenhart","year":"2018","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.09.005_bib157","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1053\/j.gastro.2011.12.056","article-title":"Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure","volume":"142","author":"Kribben","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib158","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1002\/hep.26185","article-title":"Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial","volume":"57","author":"Ba\u00f1ares","year":"2013","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib159","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/gut.2008.174615","article-title":"Molecular adsorbent recirculating system is ineffective in the management of type 1 hepatorenal syndrome in patients with cirrhosis with ascites who have failed vasoconstrictor treatment","volume":"59","author":"Wong","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.jceh.2020.09.005_bib160","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjcard.2007.10.051","article-title":"A\u00a0comparison of contemporary definitions of contrast nephropathy in patients undergoing percutaneous coronary intervention and a proposal for a novel nephropathy grading system","volume":"101","author":"Harjai","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jceh.2020.09.005_bib161","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1259\/bjr\/26964464","article-title":"Contrast media and the kidney: European Society of Urogenital Radiology (ESUR) guidelines","volume":"76","author":"Thomsen","year":"2003","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jceh.2020.09.005_bib162","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.amjmed.2010.02.026","article-title":"Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography","volume":"123","author":"Ribichini","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib163","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2214\/AJR.08.1413","article-title":"Background fluctuation of kidney function versus contrast-induced nephrotoxicity","volume":"192","author":"Bruce","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jceh.2020.09.005_bib164","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1148\/radiol.13130775","article-title":"Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate","volume":"271","author":"McDonald","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2020.09.005_bib165","first-page":"134","article-title":"Nephropathy in critically Ill patients without preexisting renal disease","volume":"48","author":"Polena","year":"2005","journal-title":"Proc West Pharmacol Soc"},{"key":"10.1016\/j.jceh.2020.09.005_bib166","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.3748\/wjg.15.1459","article-title":"Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis","volume":"15","author":"Lodhia","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib167","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2165\/00003088-200140080-00001","article-title":"Measures of exposure versus measures of rate and extent of absorption","volume":"40","author":"Chen","year":"2001","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.jceh.2020.09.005_bib168","first-page":"658","article-title":"Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention","volume":"49","author":"Nyman","year":"2008","journal-title":"Acta Radiol Stockh Swed 1987"},{"issue":"suppl 5","key":"10.1016\/j.jceh.2020.09.005_bib169","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1097\/00004424-199311001-00003","article-title":"Low-osmolality contrast media and the risk of contrast-associated nephrotoxicity","volume":"28","author":"Goldfarb","year":"1993","journal-title":"Invest Radiol"},{"key":"10.1016\/j.jceh.2020.09.005_bib170","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1148\/radiology.188.1.8511292","article-title":"Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media","volume":"188","author":"Barrett","year":"1993","journal-title":"Radiology"},{"key":"10.1016\/j.jceh.2020.09.005_bib171","article-title":"Simultaneous liver kidney transplantation","volume":"10","author":"Singal","year":"2018","journal-title":"Transpl Int Off J Eur Soc Organ Transplant. Published online December"},{"key":"10.1016\/j.jceh.2020.09.005_bib172","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1111\/j.1600-6143.2012.04190.x","article-title":"Simultaneous liver-kidney transplantation summit: current state and future directions","volume":"12","author":"Nadim","year":"2012","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jceh.2020.09.005_bib173","first-page":"1142","article-title":"Renal outcomes after liver transplantation in the model for end-stage liver disease era","volume":"15","author":"Sharma","year":"2009","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jceh.2020.09.005_bib174","first-page":"1808","article-title":"Effect of pretransplant serum creatinine on the survival benefit of liver transplantation","volume":"15","author":"Sharma","year":"2009","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jceh.2020.09.005_bib175","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00007890-200105270-00012","article-title":"Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis","volume":"71","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.09.005_bib176","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jhep.2003.09.019","article-title":"Effects of treatment of hepatorenal syndrome before transplantation on posttransplantation outcome. A case-control study","volume":"40","author":"Restuccia","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib177","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1053\/gast.2002.32364","article-title":"Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study","volume":"122","author":"Moreau","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib178","first-page":"539","article-title":"Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome","volume":"18","author":"Nadim","year":"2012","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jceh.2020.09.005_bib179","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jhep.2014.02.023","article-title":"Urinary neutrophil gelatinase-associated lipocalin predicts kidney outcome and death in patients with cirrhosis and bacterial infections","volume":"61","author":"Barreto","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib180","first-page":"1852","article-title":"Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin","volume":"15","author":"Niemann","year":"2009","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jceh.2020.09.005_bib181","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2217\/bmm.10.12","article-title":"Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury","volume":"4","author":"Devarajan","year":"2010","journal-title":"Biomarkers Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib182","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1111\/j.1600-6143.2008.02416.x","article-title":"Proceedings of consensus conference on simultaneous liver kidney transplantation (SLK)","volume":"8","author":"Eason","year":"2008","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jceh.2020.09.005_bib183","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/bja\/aeu556","article-title":"Acute kidney injury following orthotopic liver transplantation: incidence, risk factors, and effects on patient and graft outcomes","volume":"114","author":"Hilmi","year":"2015","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jceh.2020.09.005_bib184","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.transproceed.2012.09.096","article-title":"Acute kidney injury after orthotopic liver transplantation","volume":"44","author":"Karapanagiotou","year":"2012","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.09.005_bib185","first-page":"814","article-title":"Early indicators of prognosis in fulminant hepatic failure: an assessment of the Model for End-Stage Liver Disease (MELD) and King's College Hospital criteria","volume":"13","author":"Dhiman","year":"2007","journal-title":"Liver Transplant Off Publ Am Assoc Study Liver Dis Int Liver Transplant Soc"},{"key":"10.1016\/j.jceh.2020.09.005_bib186","first-page":"352","article-title":"Risk factors and outcomes of acute kidney injury in patients with acute liver failure","volume":"13","author":"Tujios","year":"2015","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"key":"10.1016\/j.jceh.2020.09.005_bib187","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s10620-015-3870-y","article-title":"Prevalence, severity, and impact of renal dysfunction in acute liver failure on the US liver transplant waiting list","volume":"61","author":"Urrunaga","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jceh.2020.09.005_bib188","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/01.tp.0000188149.90975.63","article-title":"Risk stratification of adult patients undergoing orthotopic liver transplantation for fulminant hepatic failure","volume":"81","author":"Barshes","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jceh.2020.09.005_bib189","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/j.1600-6143.2011.03649.x","article-title":"Chronic kidney disease after liver transplantation for acute liver failure is not associated with perioperative renal dysfunction","volume":"11","author":"Leithead","year":"2011","journal-title":"Am J Transplant Off J Am Soc Transplant Am Soc Transpl Surg"},{"key":"10.1016\/j.jceh.2020.09.005_bib190","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00003246-199303000-00007","article-title":"Improved cardiovascular stability during continuous modes of renal replacement therapy in critically ill patients with acute hepatic and renal failure","volume":"21","author":"Davenport","year":"1993","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib191","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/CCM.0000000000001826","article-title":"Effect of continuous renal replacement therapy on outcome in pediatric acute liver failure","volume":"44","author":"Deep","year":"2016","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib192","article-title":"US Acute Liver Failure Study Group. Continuous renal replacement therapy is associated with reduced serum ammonia levels and mortality in acute liver failure","author":"Cardoso","year":"2017","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148782","article-title":"Use of renal replacement therapy may influence graft outcomes following liver transplantation for acute liver failure: a propensity-score matched population-based retrospective cohort study","volume":"11","author":"Knight","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2020.09.005_bib194","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.transproceed.2017.03.031","article-title":"Prognostic factors predicting poor outcome in living-donor liver transplantation for fulminant hepatic failure","volume":"49","author":"Kim","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.09.005_bib195","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00535-012-0570-7","article-title":"Predicting survival after living and deceased donor liver transplantation in adult patients with acute liver failure","volume":"47","author":"Jin","year":"2012","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib196","first-page":"2276","article-title":"Renal biopsy in liver transplant recipients","volume":"24","author":"O'Riordan","year":"2009","journal-title":"Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc."},{"key":"10.1016\/j.jceh.2020.09.005_bib197","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S1499-3872(16)60167-4","article-title":"Limitations of current liver transplant immunosuppressive regimens: renal considerations","volume":"16","author":"Zhang","year":"2017","journal-title":"Hepatobiliary Pancreat Dis Int HBPD INT"},{"key":"10.1016\/j.jceh.2020.09.005_bib198","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.12872","article-title":"Everolimus with early withdrawal or reduced-dose calcineurin inhibitors improves renal function in liver transplant recipients: a systematic review and meta-analysis","volume":"31","author":"Lin","year":"2017","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jceh.2020.09.005_bib199","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-137-1-200207020-00006","article-title":"Updated definitions of healthy ranges for serum alanine aminotransferase levels","volume":"137","author":"Prati","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jceh.2020.09.005_bib200","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.23505","article-title":"Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology","volume":"51","author":"Lee","year":"2010","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib201","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1002\/hep.24725","article-title":"Upper limits of normal for alanine aminotransferase activity in the United States population","volume":"55","author":"Ruhl","year":"2012","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib202","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ajg.2016.517","article-title":"ACG clinical guideline: evaluation of abnormal liver chemistries","volume":"112","author":"Kwo","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib203","doi-asserted-by":"crossref","first-page":"271","DOI":"10.6061\/clinics\/2014(04)09","article-title":"Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review","volume":"69","author":"Sette","year":"2014","journal-title":"Clin Sao Paulo Braz"},{"key":"10.1016\/j.jceh.2020.09.005_bib204","doi-asserted-by":"crossref","first-page":"31","DOI":"10.4103\/2229-516X.149232","article-title":"A\u00a0comparative study of serum aminotransferases in chronic kidney disease with and without end-stage renal disease: need for new reference ranges","volume":"5","author":"Ray","year":"2015","journal-title":"Int J Appl Basic Med Res"},{"key":"10.1016\/j.jceh.2020.09.005_bib205","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.9036","article-title":"Non-viral related liver enzymes elevation after kidney transplantation","volume":"14","author":"Einollahi","year":"2014","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jceh.2020.09.005_bib206","doi-asserted-by":"crossref","first-page":"90","DOI":"10.4103\/ijot.ijot_6_17","article-title":"Transient abnormal liver enzyme level in the early stage after renal transplantation in children","volume":"12","author":"Alfandary","year":"2018","journal-title":"Indian J Transplant"},{"key":"10.1016\/j.jceh.2020.09.005_bib207","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.12669\/pjms.326.10725","article-title":"Analysis of liver function test abnormalities in kidney transplant recipients: 7 year experience","volume":"32","author":"Dizdar","year":"2016","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.jceh.2020.09.005_bib208","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/17474124.2017.1309280","article-title":"An update on the pathophysiology and management of polycystic liver disease","volume":"11","author":"Wong","year":"2017","journal-title":"Expet Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib209","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1002\/hep.24036","article-title":"Medical and surgical treatment options for polycystic liver disease","volume":"52","author":"Drenth","year":"2010","journal-title":"Hepatol Baltim Md"},{"key":"10.1016\/j.jceh.2020.09.005_bib210","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J\u00a0Am Soc Nephrol JASN"},{"key":"10.1016\/j.jceh.2020.09.005_bib211","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2215\/CJN.05380709","article-title":"Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotide","volume":"5","author":"Caroli","year":"2010","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.jceh.2020.09.005_bib212","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1053\/j.gastro.2009.07.052","article-title":"Lanreotide reduces the volume of polycystic liver: a randomized, double-blind, placebo-controlled trial","volume":"137","author":"van Keimpema","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib213","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.ackd.2015.06.003","article-title":"Glomerular diseases associated with hepatitis B and C","volume":"22","author":"Gupta","year":"2015","journal-title":"Adv Chron Kidney Dis"},{"key":"10.1016\/j.jceh.2020.09.005_bib214","doi-asserted-by":"crossref","first-page":"714","DOI":"10.4103\/1319-2442.235166","article-title":"Should antiviral monotherapy with nucleotide analogs be the primary treatment option for focal segmental glomerulosclerosis-related nephrotic syndrome in chronic hepatitis B infection?","volume":"29","author":"Javaid","year":"2018","journal-title":"Saudi J Kidney Dis Transplant Off Publ Saudi Cent Organ Transplant Saudi Arab"},{"key":"10.1016\/j.jceh.2020.09.005_bib215","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.2215\/CJN.09180816","article-title":"Viral-associated GN: hepatitis B and other viral infections","volume":"12","author":"Kupin","year":"2017","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"10.1016\/j.jceh.2020.09.005_bib216","article-title":"Electronic address: easloffice@easloffice.eu, European Association for the Study of the Liver. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib217","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1517\/14656566.2015.1066333","article-title":"Treatment of hepatitis C-related kidney disease","volume":"16","author":"Fabrizi","year":"2015","journal-title":"Expet Opin Pharmacother"},{"key":"10.1016\/j.jceh.2020.09.005_bib218","doi-asserted-by":"crossref","first-page":"5552","DOI":"10.3748\/wjg.v13.i42.5552","article-title":"Acute renal dysfunction in liver diseases","volume":"13","author":"Betrosian","year":"2007","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jceh.2020.09.005_bib219","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000313759","article-title":"Management of acute kidney injury in liver disease","volume":"165","author":"Davenport","year":"2010","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jceh.2020.09.005_bib220","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1525-139X.2011.00827.x","article-title":"Renal replacement therapy in special settings: extracorporeal support devices in liver failure","volume":"24","author":"Cerd\u00e1","year":"2011","journal-title":"Semin Dial"},{"key":"10.1016\/j.jceh.2020.09.005_bib221","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/cc10499","article-title":"Clinical review: use of renal replacement therapies in special groups of ICU patients","volume":"16","author":"Hoste","year":"2012","journal-title":"Crit Care Lond Engl"},{"key":"10.1016\/j.jceh.2020.09.005_bib222","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1525-139X.2008.00539.x","article-title":"Continuous renal replacement therapies in patients with liver disease","volume":"22","author":"Davenport","year":"2009","journal-title":"Semin Dial"},{"key":"10.1016\/j.jceh.2020.09.005_bib223","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.jcrc.2015.06.006","article-title":"Sustained low-efficiency dialysis with regional citrate anticoagulation in medical intensive care unit patients with liver failure: a prospective study","volume":"30","author":"Lahmer","year":"2015","journal-title":"J\u00a0Crit Care"},{"key":"10.1016\/j.jceh.2020.09.005_bib224","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.transproceed.2017.02.025","article-title":"Safety and efficacy of citrate anticoagulation for continuous renal replacement therapy for acute kidney injury after liver transplantation: a single-center experience","volume":"49","author":"Pertica","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jceh.2020.09.005_bib225","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000480224","article-title":"Higher versus lower continuous renal replacement therapy intensity in critically ill patients with liver dysfunction","volume":"45","author":"O'Brien","year":"2018","journal-title":"Blood Purif"},{"key":"10.1016\/j.jceh.2020.09.005_bib226","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000314854","article-title":"Blood purification in fulminant hepatic failure","volume":"166","author":"Shinozaki","year":"2010","journal-title":"Contrib Nephrol"},{"key":"10.1016\/j.jceh.2020.09.005_bib227","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2015.08.018","article-title":"High-volume plasma exchange in patients with acute liver failure: an open randomised controlled trial","volume":"64","author":"Larsen","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib228","first-page":"1","article-title":"Expanding the boundaries of combined renal replacement therapy for non-renal indications","author":"Kamboj","year":"2018","journal-title":"Blood Purif"},{"key":"10.1016\/j.jceh.2020.09.005_bib229","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044269","article-title":"Mapping the aetiology of non-malarial febrile illness in Southeast Asia through a systematic review--terra incognita impairing treatment policies","volume":"7","author":"Acestor","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.jceh.2020.09.005_bib230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002331","article-title":"Dengue and other common causes of acute febrile illness in Asia: an active surveillance study in children","volume":"7","author":"Capeding","year":"2013","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.jceh.2020.09.005_bib231","first-page":"37","article-title":"A\u00a0study of clinical profile of patients presenting with complications of acute febrile illnesses during monsoon","volume":"65","author":"Salagre","year":"2017","journal-title":"J\u00a0Assoc Phys India"},{"key":"10.1016\/j.jceh.2020.09.005_bib232","series-title":"Viral Hepatitis in Indian Subcontinent","first-page":"91","article-title":"Non-viral infective and non-infective mimics of hepatitis","author":"Kumar","year":"2017"},{"issue":"suppl 1","key":"10.1016\/j.jceh.2020.09.005_bib233","doi-asserted-by":"crossref","first-page":"S116","DOI":"10.1016\/j.jceh.2014.05.007","article-title":"Approach to clinical syndrome of jaundice and encephalopathy in tropics","volume":"5","author":"Anand","year":"2015","journal-title":"J\u00a0Clin Exp Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib234","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.cmrp.2018.08.001","article-title":"Liver involvement in common febrile illnesses","volume":"8","author":"Kumar","year":"2018","journal-title":"Curr Med Res Pract"},{"key":"10.1016\/j.jceh.2020.09.005_bib235","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2020.09.005_bib236","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1053\/j.gastro.2016.12.026","article-title":"American gastroenterological association institute guidelines for the diagnosis and management of acute liver failure","volume":"152","author":"Flamm","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2020.09.005_bib237","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/j.ajkd.2017.11.021","article-title":"Management of acute kidney injury: core curriculum 2018","volume":"72","author":"Moore","year":"2018","journal-title":"Am J Kidney Dis Off J Natl Kidney Found"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320301444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688320301444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:07:02Z","timestamp":1760854022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688320301444"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":236,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0973688320301444"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2020.09.005","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"INASL-ISN Joint Position Statements on Management of Patients with Simultaneous Liver and Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2020.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}